Zimmer Biomet Holdings Inc (ZBH):企業の財務・戦略的SWOT分析

◆英語タイトル:Zimmer Biomet Holdings Inc (ZBH) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1301
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:60
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Zimmer Biomet Holdings Inc (ZBH) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Zimmer Biomet Holdings Inc (Zimmer Biomet) is a medical device company that focuses on musculoskeletal healthcare. The company designs, manufactures, and markets orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, craniomaxillofacial and thoracic products; office based technologies; dental implants; and related surgical products. Its products and solutions assist in treating patients suffering from disorders or injuries in bones, joints and supporting soft tissues. Zimmer Biomet offers products to orthopaedic surgeons, oral surgeons, neurosurgeons, other specialists, dentists, stocking distributors, hospitals, healthcare dealers and healthcare purchasing organizations. The company markets products through direct sales channels and distributors in Americas, Europe, Asia-Pacific, the Middle East and Africa. Zimmer Biomet is headquartered in Warsaw, Indiana, the US.

Zimmer Biomet Holdings Inc Key Recent Developments

Mar 10,2020: Zimmer Biomet Announces Quarterly Dividend for First Quarter of 2020
Feb 28,2020: Zimmer Biomet Holdings to Present at Raymond James & Associates’ 41st Annual Institutional Investors Conference
Feb 04,2020: Zimmer Biomet announces fourth quarter and full-year 2019 financial results
Jan 08,2020: Zimmer Biomet appoints Keri P. Mattox as Senior Vice President of Investor Relations and Chief Communications Officer

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Zimmer Biomet Holdings Inc – Key Facts
Zimmer Biomet Holdings Inc – Key Employees
Zimmer Biomet Holdings Inc – Key Employee Biographies
Zimmer Biomet Holdings Inc – Major Products and Services
Zimmer Biomet Holdings Inc – History
Zimmer Biomet Holdings Inc – Company Statement
Zimmer Biomet Holdings Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Zimmer Biomet Holdings Inc – Business Description
Product Category: Dental
Overview
Performance
Product Category: Hips
Overview
Performance
Product Category: Knees
Overview
Performance
Product Category: Other
Overview
Performance
Product Category: S.E.T
Overview
Performance
Product Category: Spine & CMF
Overview
Performance
Geographical Segment: Americas
Target Markets
Performance
Geographical Segment: Asia Pacific
Target Markets
Performance
Geographical Segment: EMEA
Target Markets
Performance
R&D Overview
Zimmer Biomet Holdings Inc – Corporate Strategy
Zimmer Biomet Holdings Inc – SWOT Analysis
SWOT Analysis – Overview
Zimmer Biomet Holdings Inc – Strengths
Zimmer Biomet Holdings Inc – Weaknesses
Zimmer Biomet Holdings Inc – Opportunities
Zimmer Biomet Holdings Inc – Threats
Zimmer Biomet Holdings Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Zimmer Biomet Holdings Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Zimmer Biomet Holdings Inc, Medical Equipment, Deals By Type, 2014 to YTD 2020
Zimmer Biomet Holdings Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 04, 2020: Zimmer Biomet announces fourth quarter and full-year 2019 financial results
Jan 08, 2020: Zimmer Biomet appoints Keri P. Mattox as Senior Vice President of Investor Relations and Chief Communications Officer
Nov 05, 2019: Zimmer Biomet announces third quarter 2019 financial results
Jul 26, 2019: Zimmer Biomet announces second quarter 2019 financial results
Jun 19, 2019: Zimmer Biomet announces chief financial officer transition plan
Apr 26, 2019: Zimmer Biomet announces first quarter 2019 financial results
Feb 01, 2019: Zimmer Biomet announces fourth quarter and full-year 2018 financial results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Zimmer Biomet Holdings Inc, Key Facts
Zimmer Biomet Holdings Inc, Key Employees
Zimmer Biomet Holdings Inc, Key Employee Biographies
Zimmer Biomet Holdings Inc, Major Products and Services
Zimmer Biomet Holdings Inc, History
Zimmer Biomet Holdings Inc, Subsidiaries
Zimmer Biomet Holdings Inc, Key Competitors
Zimmer Biomet Holdings Inc, Ratios based on current share price
Zimmer Biomet Holdings Inc, Annual Ratios
Zimmer Biomet Holdings Inc, Annual Ratios (Cont...1)
Zimmer Biomet Holdings Inc, Annual Ratios (Cont...2)
Zimmer Biomet Holdings Inc, Interim Ratios
Zimmer Biomet Holdings Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Zimmer Biomet Holdings Inc, Medical Equipment, Deals By Type, 2014 to YTD 2020
Zimmer Biomet Holdings Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Zimmer Biomet Holdings Inc, Performance Chart (2015 - 2019)
Zimmer Biomet Holdings Inc, Ratio Charts
Zimmer Biomet Holdings Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Zimmer Biomet Holdings Inc, Medical Equipment, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Zimmer Biomet Holdings Inc (ZBH):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hawkins Inc (HWKN):企業の財務・戦略的SWOT分析
    Hawkins Inc (HWKN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Dogus Otomotiv Servis ve Ticaret AS:戦略・SWOT・企業財務分析
    Dogus Otomotiv Servis ve Ticaret AS - Strategy, SWOT and Corporate Finance Report Summary Dogus Otomotiv Servis ve Ticaret AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Ansvar Insurance Limited:企業の戦略・SWOT・財務分析
    Ansvar Insurance Limited - Strategy, SWOT and Corporate Finance Report Summary Ansvar Insurance Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Chariot Oil & Gas Ltd (CHAR):石油・ガス:M&Aディール及び事業提携情報
    Summary Chariot Oil & Gas Ltd (CHAR) is an oil and gas exploration company that create transformational stakeholder value through the discovery of material accumulations of hydrocarbons. The company provides services such as drilling and extracting services for oil and gas resources. It also offers …
  • Pulmonx Corp:医療機器:M&Aディール及び事業提携情報
    Summary Pulmonx Corp (Pulmonx) is a medical device company that manufactures and markets minimally invasive medical devices and technologies for the diagnosis and treatment of pulmonary disorders. The company uses combination of assessment tools and therapeutics which enables physicians to successfu …
  • State Bank Of India:企業の戦略・SWOT・財務分析
    State Bank Of India - Strategy, SWOT and Corporate Finance Report Summary State Bank Of India - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Eriks NV:企業のM&A・事業提携・投資動向
    Eriks NV - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Eriks NV Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital …
  • Global Clean Energy Holdings Inc:企業の戦略的SWOT分析
    Global Clean Energy Holdings Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Symbolic Displays Inc:企業の戦略・SWOT・財務情報
    Symbolic Displays Inc - Strategy, SWOT and Corporate Finance Report Summary Symbolic Displays Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Numab Innovation AG-製薬・医療分野:企業M&A・提携分析
    Summary Numab Innovation AG (Numab) designs and develops novel therapeutics for the treatment of severe diseases. The company’s lead program ND007, a bispecific antibody fragment which is being evaluated for the treatment of autoimmune diseases. Numab’s other pipeline drug candidates include ND009, …
  • The Juroku Bank Ltd:企業の戦略・SWOT・財務情報
    The Juroku Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary The Juroku Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Caterpillar Inc.:戦略・SWOT・企業財務分析
    Caterpillar Inc. - Strategy, SWOT and Corporate Finance Report Summary Caterpillar Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Tox Free Solutions Limited (TOX):企業の財務・戦略的SWOT分析
    Tox Free Solutions Limited (TOX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • EVN AG (EVN):企業の財務・戦略的SWOT分析
    EVN AG (EVN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • Mita-Teknik AS:企業の戦略的SWOT分析
    Mita-Teknik AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Israel Institute of Technology:製薬・医療:M&Aディール及び事業提携情報
    Summary Israel Institute of Technology (Technion) is a research university that offers science and technology programs. The university offers various undergraduate and graduate programs in biology, biomedical engineering, biotechnology and food engineering, chemical engineering, and medicine and env …
  • Cree Inc (CREE):電力:M&Aディール及び事業提携情報
    Summary Cree, Inc (Cree) is a provider of semiconductor and lighting products for radio-frequency (RF) and power applications. The company’s product portfolio includes LED chips, LED components and LED lighting solutions and SiC and GaN materials and products. It also offers power and radio frequenc …
  • SELLAS Life Sciences Group Inc (SLS):医療機器:M&Aディール及び事業提携情報
    Summary SELLAS Life Sciences Group Inc (SELLAS), formerly Galena Biopharma Inc, is a clinical-stage biopharmaceutical company that develops novel cancer immunotherapeutics for a broad range of cancer indications. Its lead product candidate, galinpepimut-S, is a Wilms Tumor 1 (WT1) protein-targeting …
  • Nippon Yusen Kabushiki Kaisha (9101)-石油・ガス分野:企業M&A・提携分析
    Summary Nippon Yusen Kabushiki Kaisha (NYK) is a logistics company transporting crude oil and allied products. The company provides ocean, land, and air transport services for the transportation of petroleum products, liquid products and dry bulk products. Its portfolio includes line trade, air carg …
  • PDL BioPharma Inc (PDLI):製薬・医療:M&Aディール及び事業提携情報
    Summary PDL BioPharma Inc (PDL) formerly Protein Design Labs, Inc., manages a portfolio of patents and royalty assets that include Queen et al. patents and license agreements with various pharmaceutical and biotechnology companies, and royalty and other acquired assets. It offers financing solutions …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆